PAGE 54 / MAY 25, 2008 S C R I P T D O C T O R : M E D I C I N E I N T H E M E D I A Dateline Nigeria (Part 3): Creating Solutions When Despite Public Service Announcements, Ads, &Documentaries, Many Women Were Still Not Seeking Life-Saving Treatment
that was created aftera well-meaning health
Andrew Holtz, MPH, is a “Sànnu.” former CNN Medical Correspondent and the author of “The Medical Science of House, M.D.” Send questions to him about how the media treat medical topics or suggestions for future columns
patients don’t seem to really hear what
to OT@lwwny.com
Nigeria have obstetric fistulae. To try to
clinics to repair the holes and alleviate
the related incontinence, infections, and
then together sketched out a story arc.
As a result, radio listeners heard stories
the focus on what’s relevant and inter-
variety show Ya Take Ne (What’s Up?).
regime in Kano state say ‘sex,’” she
without saying ‘sex’? She said you talk
Putting Storytelling First
those who tuned in to Gugar Goge were
by the program,” Christine K said. Parts I and 2 of this series appeared in the April 25 and May 10 issues.
a radio soap opera called Gugar Goge(Tell Me Straight). Rather than building
with anastrozole,” Dr. Singh said. Bisphosphonates Oral vs. IV
ty as detected in imaging studies or if a
group, there was not a “big difference”
oncologists tend to reach for oral bispho-
significantly greater with anastrozole,”
of osteoporosis, albeit outside of the con-
significant difference of 6.7% in favor of
the upfront group, Dr. Brufsky reported.
porosis, “they are not always well toler-
PAGE 55 / MAY 25, 2008 IP Therapy Still Overlooked for Ovarian Cancer Issues of toxicity and complexity continue to concern clinicians in deciding about using
Dedrick, PhD, et al published in CancerTherapy Reports indicating that certain
NEW YORK CITY—Issues of tox-
icity and complexity continue tocause intraperitoneal therapy tobe overlooked by clinicians in
intraperitoneal therapy for ovarian cancer.
overall survival. So said presenters here
Symposium in discussions that re-viewed the latest therapeutic research.
nique, Maurie Markman, MD, VicePresident for Clinical Research andProfessor and Chair of GynecologicMedical Oncology at the University ofTexas M. D. Anderson Cancer Center,noted that since ovarian cancer mostlyremains confined to the peritoneal cav-ity, researchers in the early 1950s intro-duced the idea of administering che-motherapy intraperitoneally. However,
ScriptDoctor continued from page 54
pregnancy carries health risks forwomen. ‘See the Characters as Human Beings’
“One striking thing that surprises meevery day is that people can actuallyidentify our characters, people canactually tell you the circumstances, peo-ple see the characters as humanbeings,” Asangaeneng said, adding thatthe characters have become role mod-els, their names entering everyday con-versations.
sometimes even has consequences forthe actors.
during a [Population Media Center]program,” Asangaeneng recalled, “theactor of a particular character that wasagainst gender equity was pelted withtomatoes by women in the market,because they believed his actions werereal. They never even considered hewas [acting] in the context of a drama.”
CHIP TAYLOR FACT FILE Early Years • Born James Wesley Voight and raised in Yonkers, NY, the son of a professional golfer, Taylor is the brother of Academy Award-winning actor Jon Voight and noted geologist Barry Voight, who devised the formula to predict the elusive occurrences of volcanic eruptions. • Absorbed in music as a youth and keying in to Country & Western via the 50,000
PHYSICIANS CIRCULAR RENITEC®† RENITEC (enalapril maleate, USP) is the maleate salt of enalapril, a derivative of two amino-acids, L-alanine and L-proline. Following oral administration, enalapril is rapidly absorbed and then hydrolyzed to enalaprilat, which is a highly specific, long-acting, non-sulphydryl angiotensin converting enzyme inhibitor. RENITEC is indicated in the treatment o
PAGE 54 / MAY 25, 2008